By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
An inhaler is a medical device used to administer medications into the lungs by the action of breathing. It is also referred to as a puffer, pump, or allergy spray.
In addition to enabling tailored medical therapy for this particular area of the body, it also reduces the negative effects of oral medications by enabling drug delivery to and absorption in the lungs.
Asthma and chronic obstructive pulmonary disease (COPD) are two of the many medical illnesses that are widely treated with inhalers, which come in a wide range.
The pressurised metered-dose inhaler (MDI), the most popular kind of inhaler, consists of three standard parts: a metal canister, a plastic actuator, and a metering valve.
A medical device known as an inhaler is used to deliver drugs into the lungs by breathing. It’s also known as an allergy spray, a puffer, or a pump.
It not only makes it possible for specialised medical treatment for this area of the body, but it also lessens the side effects of oral medications by making it possible for drug transport to and absorption in the lungs.
Two of the many medical conditions that are frequently treated with inhalers, which come in a variety of shapes and sizes, are asthma and chronic obstructive pulmonary disease (COPD).
The most common type of inhaler, the pressurised metered-dose inhaler (MDI), has three standard components: a metal canister, a plastic actuator, and a metering valve.
This may help a patient by delivering medications right to the site of the ailment, allowing them to have a stronger impact on their intended goal, and reducing adverse effects when prescribed locally.
Inhalers are used to treat a wide range of medical disorders, with respiratory and lung ailments being among the most often treated. To make breathing simpler and more comfortable, people with these diseases or disorders need drugs that reduce airway inflammation and blockage.
Even antibiotics for inhalers have been created to deliver the drugs directly to the infected lung tissue. Asthma and chronic obstructive pulmonary disease are two of the most typical illnesses that need inhaler therapy.
A plastic hand-operated actuator that holds the MDI canister is made of plastic. A fixed dose of medication in aerosol form is released by the metered-dose inhaler’s actuator into the patient’s lungs upon activation.
Due to the fact that the medication must be released at or almost at the same time as inhalation for it to be effective, these devices call for considerable coordination.
The smart-inhaler is an inhaler that uses sensor technology to automatically update an app with data on the time of day, the quality of the air, and how frequently it has been used.
The Global inhaler materials market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
HeroTracker Sense is a digital respiratory health solution that transforms a typical metered dose inhaler (pMDI) into a smart linked healthcare device, according to Aptar Pharma, a company that specialises in medicine delivery, services, and active material science solutions.
HeroTracker Sense is made to measure MDI usage and promote better adherence to prescribed medication for people suffering from chronic respiratory disorders like asthma, COPD, Cystic Fibrosis, and other respiratory conditions around the world.
A metered-dose inhaler (MDI) add-on linked gadget called HeroTracker Sense was created to address patient inhalation technique and adherence.
The use of pressurised metered dose inhalers (MDIs) has been around for a while to treat lung conditions like asthma and chronic obstructive pulmonary disease.
MDIs rely on the propellant, which makes up the majority of the MDI formulation, to atomize medication and excipient droplets, which should ideally deposit in the lungs.
Many improvements were made to the processes of formulating for MDI drug delivery during the phase-out of chlorofluorocarbon propellants and the introduction of more environmentally friendly hydrofluoroalkane propellants, along with a greater understanding of formulation variables on product performance.
This paper examines the difficulties in manufacturing MDIs as solutions or suspensions containing one or more medications, taking into account the physicochemical characteristics of different excipients and the potential effects of their addition.
